According to Prelude Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$1.03 Billion a decrease over its 2022 earnings that were of -HK$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.